![](/img/cover-not-exists.png)
A drug–drug interaction study of ibrutinib with moderate/strong CYP3A inhibitors in patients with B-cell malignancies
de Jong, Jan, Hellemans, Peter, De Wilde, Severijn, Patricia, Daniel, Masterson, Tara, Manikhas, Georgii, Myasnikov, Alexander, Osmanov, Dzhelil, Córdoba, Raúl, Panizo, Carlos, de Zwart, Loeckie, SnoeLanguage:
english
Journal:
Leukemia & Lymphoma
DOI:
10.1080/10428194.2018.1460474
Date:
May, 2018
File:
PDF, 1005 KB
english, 2018